Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria
Open Access
- 1 October 2002
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (10) , 3283-3285
- https://doi.org/10.1128/aac.46.10.3283-3285.2002
Abstract
By using current NCCLS broth microdilution methods, we found that gatifloxacin inhibited 90% of the isolates of the Mycobacterium fortuitum group at ≤0.12 μg/ml and 90% of the Mycobacterium chelonae isolates at ≤4 μg/ml. Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria.Keywords
This publication has 10 references indexed in Scilit:
- Successful Treatment of DisseminatedMycobacterium chelonaeInfection with LinezolidClinical Infectious Diseases, 2001
- Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudo-outbreaks and contaminated metalworking fluids: an international cooperative study on mycobacterial taxonomy.International Journal of Systematic and Evolutionary Microbiology, 2001
- Can antimicrobial susceptibility testing results for ciprofloxacin or levofloxacin predict susceptibility to a newer fluoroquinolone, gatifloxacin?: Report from The SENTRY Antimicrobial Surveillance Program (1997–99)Diagnostic Microbiology and Infectious Disease, 2001
- Activities of Linezolid against Rapidly Growing MycobacteriaAntimicrobial Agents and Chemotherapy, 2001
- Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial TaxonomyInternational Journal of Systematic and Evolutionary Microbiology, 1999
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- Rapid Development of Resistance to Clarithromycin Following Monotherapy for Disseminated Mycobacterium chelonae Infection in a Heart Transplant PatientClinical Infectious Diseases, 1995
- Skin, Soft Tissue, and Bone Infections Due to Mycobacterium chelonae chelonae: Importance of Prior Corticosteroid Therapy, Frequency of Disseminated Infections, and Resistance to Oral Antimicrobials Other than ClarithromycinThe Journal of Infectious Diseases, 1992
- Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial Agents and Chemotherapy, 1992
- Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapyAntimicrobial Agents and Chemotherapy, 1990